We analyzed similar studies that included all NSCLC stages; Huang et al. developed models that predicted OS in the anaplastic lymphoma kinase (ALK+) set, which achieved a C-index of 0.649 (95% confidence interval, 0.640–0.658) [25]. Here, ALK is linked to non-small cell lung carcinoma.